CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection

The oncoprotein Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) is overexpressed in most malignancies and is an obvious candidate target protein for future cancer therapies. However, the physiological importance of CIP2A-mediated PP2A inhibition is largely unknown. As PP2A regulates immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: Côme, Christophe, Cvrljevic, Anna, Khan, Mohd Moin, Treise, Irina, Adler, Thure, Aguilar-Pimentel, Juan Antonio, Au-Yeung, Byron, Sittig, Eleonora, Laajala, Teemu Daniel, Chen, Yiling, Oeder, Sebastian, Calzada-Wack, Julia, Horsch, Marion, Aittokallio, Tero, Busch, Dirk H., Ollert, Markus W., Neff, Frauke, Beckers, Johannes, Gailus-Durner, Valerie, Fuchs, Helmut, de Angelis, Martin Hrabě, Chen, Zhi, Lahesmaa, Riitta, Westermarck, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839633/
https://www.ncbi.nlm.nih.gov/pubmed/27100879
http://dx.doi.org/10.1371/journal.pone.0152996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839633/
https://www.ncbi.nlm.nih.gov/pubmed/27100879
http://dx.doi.org/10.1371/journal.pone.0152996

Ejemplares similares